Publication | Closed Access

A randomised trial comparing two doses of the new selective aromatase inhibitor anastrozole (Arimidex) with megestrol acetate in postmenopausal patients with advanced breast cancer *

Megestrol AcetateBreast OncologyOncologyMedicineRandomised TrialBreast CancerPharmacotherapyAromatasePharmacologyRadiation OncologyPostmenopausal PatientsEndocrine-related CancerMenopause Hormone Therapy